FDA Inspection 810435 — Oklahoma Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute on Oct 11, 2012 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 11, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Oklahoma City, OK (United States)